Skip to content
Home » IP 109 PILL – Identification, Dosage, Side Effects

IP 109 PILL – Identification, Dosage, Side Effects

IP 109 PILL

The pill imprinted with “IP 109” is a widely prescribed prescription medication used to manage moderate to severe acute pain (Habibi, 2018). It is a combination drug containing an opioid pain reliever and a non-opioid analgesic (Godman et al., 2020).

Pill Identification

IP 109 PILL
IP 109 PILL

Accurately verifying a medication by its physical characteristics is a critical safety step to prevent medication errors.

  • Imprint: IP 109
  • Active Ingredients: Hydrocodone Bitartrate 5 mg and Acetaminophen 325 mg (Habibi, 2018)
  • Color: White
  • Shape: Oval (or capsule-shaped / oblong)
  • Score Line: It typically features a debossed score line on one side to allow the tablet to be split if directed by a physician.
  • Manufacturer: Amneal Pharmaceuticals

Mechanism of Action

The “IP 109” pill achieves its therapeutic effect through the synergistic combination of its two active components, which target pain via entirely different biochemical pathways (Habibi, 2018).

Hydrocodone Bitartrate (5 mg)

Hydrocodone is a semisynthetic, full opioid agonist (Habibi, 2018; Manchikanti et al., 2017).

  • Central Nervous System (CNS) Action: It binds primarily to opioid receptors (mu-opioid receptors) in the brain and spinal cord (Habibi, 2018).
  • Pain Alteration: Activation of these receptors inhibits the release of nociceptive (pain-signaling) neurotransmitters and activates descending pain-inhibitory pathways. This fundamentally alters how the central nervous system perceives and emotionally responds to pain (Habibi, 2018).

Acetaminophen (325 mg)

Acetaminophen (also known internationally as paracetamol) is a non-opioid, non-salicylate analgesic and antipyretic (fever reducer) (Habibi, 2018; Raffa, 2014).

  • Peripheral and Central Action: While its exact mechanism is complex, it is widely understood to inhibit cyclooxygenase (COX) enzymes in the central nervous system, reducing the synthesis of prostaglandins—lipids that amplify pain signals.
  • Synergistic Effect: By blocking pain signals peripherally and centrally via non-opioid pathways, acetaminophen enhances the pain-relieving efficacy of hydrocodone without increasing opioid-related side effects (Habibi, 2018).

Dosage and Administration

Dosage must be strictly individualized by a healthcare provider based on the severity of the pain, patient response, and prior analgesic experience.

  • Standard Adult Dose: The typical initial dose is 1 to 2 tablets every 4 to 6 hours as needed for pain (Habibi, 2018).
  • Maximum Daily Ceiling: The absolute maximum daily dose is governed by the risk of acetaminophen-induced hepatotoxicity (liver damage). Adults should not exceed 4,000 mg (4 grams) of acetaminophen in a 24-hour period (Habibi, 2018). For the IP 109 formulation, this equates to a hard ceiling of 8 tablets per day, provided no other acetaminophen-containing products are consumed (Habibi, 2018).
  • Administration Guidelines: The tablet should be swallowed whole with water. Crushing, chewing, or dissolving the tablet can cause a rapid, unsafe release of the opioid component (Habibi, 2018). It can be taken with or without food; taking it with food may minimize nausea.

Side Effects

Side effects range from mild, manageable discomforts to severe, life-threatening complications.

Common Side Effects

These reactions are frequent but generally manageable under medical supervision:

  • Drowsiness, dizziness, or lightheadedness
  • Nausea, vomiting, and constipation
  • Mild itching or skin rash
  • Headache or blurred vision

Serious Side Effects

If any of the following occur, immediate medical intervention is required:

  • Respiratory Changes: Slow, shallow, or labored breathing (signs of respiratory depression) (Habibi, 2018).
  • Severe Allergic Reaction (Anaphylaxis): Swelling of the face, tongue, or throat, severe dizziness, and difficulty breathing.
  • Adrenal Insufficiency: Nausea, vomiting, loss of appetite, worsening tiredness, or dizziness.
  • Serotonin Syndrome: Agitation, hallucinations, rapid heart rate, muscle twitching, or severe coordination loss (especially when combined with certain antidepressants).

Warnings and Boxed Alerts

Because it contains a potent opioid, the IP 109 pill carries severe, federally mandated regulatory warnings (Habibi, 2018).

FDA Black Box Warnings

  • Addiction, Abuse, and Misuse: Hydrocodone exposes users to the risks of opioid addiction, which can lead to overdose and death (Habibi, 2018; Manchikanti et al., 2017).
  • Life-Threatening Respiratory Depression: Serious, life-threatening, or fatal respiratory depression may occur, particularly during initiation or following a dose increase (Habibi, 2018).
  • Accidental Ingestion: Accidental ingestion of even one dose, especially by children, can result in a fatal hydrocodone overdose (Habibi, 2018).
  • Neonatal Opioid Withdrawal Syndrome (NOWS): Prolonged use during pregnancy can result in life-threatening withdrawal symptoms in the newborn.
  • Cytochrome P450 (CYP3A4) Interactions: Concomitant use with drugs that inhibit or induce CYP3A4 enzymes can alter plasma concentrations of hydrocodone, leading to fatal toxicity or reduced efficacy (Habibi, 2018).
  • Hepatotoxicity: Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant or death, typically associated with doses exceeding limits or combining multiple acetaminophen products (Habibi, 2018).

Precautions and Contraindications

Absolute Contraindications

Do not take IP 109 if you have:

  • Significant respiratory depression or severe asthma (Habibi, 2018).
  • A known or suspected gastrointestinal obstruction, including paralytic ileus.
  • A known hypersensitivity to hydrocodone or acetaminophen (Habibi, 2018).

Critical Precautions

  • Alcohol & CNS Depressants: Do not consume alcohol or take other sedatives (like benzodiazepines or sleep aids) while using this medication. Doing so exponentially increases the risk of profound sedation, respiratory depression, coma, and death (Habibi, 2018).
  • Liver and Kidney Disease: Patients with pre-existing hepatic impairment must exercise extreme caution due to the risk of acute liver failure from the acetaminophen component (Habibi, 2018).
  • The “Hidden” Acetaminophen Risk: Always check the labels of over-the-counter cough, cold, or sinus medications. Many contain acetaminophen, and taking them alongside IP 109 can easily cause an accidental, dangerous overdose (Habibi, 2018).

Leave a Reply